4.7 Article

Rapid microfluidic platform for screening and enrichment of cells secreting virus neutralizing antibodies

期刊

LAB ON A CHIP
卷 22, 期 13, 页码 2578-2589

出版社

ROYAL SOC CHEMISTRY
DOI: 10.1039/d2lc00018k

关键词

-

资金

  1. Agency for Science, Technology and Research (A*STAR)
  2. National Medical Research Council of Singapore [MOH-000219-00, NMRC/OF-YIRG19nov-0059]
  3. Singapore Ministry of Education [MOE-000063]

向作者/读者索取更多资源

The DROP-PEARL platform is a multi-module droplet-based platform that enables high-throughput enrichment of antibody-secreting cells (ASCs) based on their neutralizing activity. It has the potential to accelerate the discovery of neutralizing antibodies against pathogenic viruses, making it useful in the ongoing fight against biological threats.
As part of the body's immune response, antibodies (Abs) have the ability to neutralize pathogenic viruses to prevent infection. To screen for neutralizing Abs (nAbs) from the immune repertoire, multiple screening techniques have been developed. However, conventional methods have a trade-off between screening throughput and the ability to screen for nAbs via their functional efficacy. Although droplet microfluidic platforms have the ability to bridge this disparity, the majority of such reported platforms still rely on Ab-binding assays as a proxy for function, which results in irrelevant hits. Herein, we report the multi-module Droplet-based Platform for Effective Antibody RetrievaL (DROP-PEARL) platform, which can achieve high-throughput enrichment of Ab-secreting cells (ASCs) based on the neutralizing activity of secreted nAbs against the a target virus. In this study, in-droplet Chikungunya virus (CHIKV) infection of host cells and neutralization was demonstrated via sequential delivery of viruses and host cells via picoinjection. In addition, we demonstrate the ability of the sorting system to accurately discriminate and isolate uninfected droplets from a mixed population of droplets at a rate of 150 000 cells per hour. As a proof of concept, a single-cell neutralization assay was performed on two populations of cells (nAb-producing and non-Ab producing cells), and up to 2.75-fold enrichment of ASCs was demonstrated. Finally, we demonstrated that DROP-PEARL is able to achieve similar enrichment for low frequency (similar to 2%) functional nAb-producing cells in a background of excess cells secreting irrelevant antibodies, highlighting its potential prospect as a first round enrichment platform for functional ASCs. We envision that the DROP-PEARL platform could potentially be used to accelerate the discovery of nAbs against other pathogenic viral targets, and we believe it will be a useful in the ongoing fight against biological threats.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据